Inogen | INGN - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Accuray USD 199.44M 4.83M 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 92.7M 8.86M 2026-03
AtriCure USD 73.19M 8.33M 2026-03
Baxter International USD 3.69B 723M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Chart Industries USD 1.87B 253.9M 2026-03
Cooper Companies USD 1.8B 209M 2026-03
Dexcom USD 2.22B 81.3M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Globus Medical USD 482.46M 16.04M 2026-03
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 687.5M 7.4M 2026-03
Medtronic USD 9.5B 440M 2025-12
Orthofix International USD 161.03M 9.45M 2026-03
Philips EUR 7.43B 78M 2026-03
ResMed USD 1.35B 103.1M 2026-03
Steris USD 1.14B 222.7M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
X T L Biopharmaceuticals USD 761K 1.45M 2025-06
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03